Clinical Trial Update: A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for OHB-607 to prevent bronchopulmonary dysplasia in extremely premature infants, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Intraventricular Hemorrhage
• Lung Disease of Prematurity
• Retinopathy of Prematurity

Drugs mentioned

• OHB-607

Snippet

Sponsor: OHB Neonatology Ltd. | Conditions: Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity | Phase 2 | Status: RECRUITING